Collaborative Care for Women Veterans (CCWV)

August 30, 2023 updated by: VA Office of Research and Development

Implementation of Tailored Collaborative Care For Women Veterans (CCWV) (QUE 15-272)

Implementation of Tailored Collaborative Care for Women Veterans (CCWV) was designed to enhance primary care-mental health integration for women Veterans by tailoring services to women Veterans' and providers' needs and providing an evidence-based intervention, Coordinated Anxiety Learning and Management, to address anxiety and depression in a patient-centered approach. CCWV was implemented in two of the Women's Health Practice-Based Research Network sites, with careful attention to local tailoring and adaptation to enhance the fit of the care model in varied local contexts.

Study Overview

Detailed Description

Background: Women Veterans are the fastest growing segment of Veterans Health Administration (VHA) users. This dramatic growth has created challenges for VHA. Gender disparities persist in cardiovascular (CV) and diabetes risk factor control, and rates of depression, anxiety, and mental health comorbidity are disproportionately high among women Veterans. Furthermore, a high rate of women Veterans' attrition from VA care, along with organizational barriers to care, substantiate that organizational changes are needed in order to engage and retain women Veteran VHA users in evidence-based, patient-centered care.

Objectives: The Enhancing Mental and Physical health of Women through Engagement and Retention (EMPOWER) QUERI addresses VHA Blueprint for Excellence Strategy 6, by advancing "personalized, proactive, patient-centered" care models, and Transformational Strategy 7.2.g by implementation of innovative care models in women Veterans' health care." The EMPOWER QUERI Program was designed to improve women Veterans' engagement and retention in evidence-based care for three high priority health conditions, i.e., prediabetes, cardiovascular, and mental health. To achieve this impact goal, the investigators proposed a cohesive portfolio of projects with the following aims: (1) To use an evidence-based implementation strategy that emphasizes local tailoring of care models, multilevel stakeholder engagement, and systematic evaluation of complex implementation processes in order to enrich organizational capacity for innovations in women Veterans' VHA health care; (2) To implement personalized, proactive, patient-centered innovations in VHA women's health that are acceptable, feasible, satisfactory, relevant, and effective for both providers and patients, thereby encouraging women Veterans' engagement and retention and sustainability of the innovations; and, (3) To generate implementation "playbooks" for the investigators' partners that are scalable and serve as guidance for future implementation of a broader array of evidence-based women's health programs and policy.

Methods: Three projects were conducted by an experienced multidisciplinary team. This trial pertains to "Implementation of Tailored Collaborative Care for Women Veterans," which evaluated implementation of an evidence-based collaborative care model tailored to enhance provider- and system-level capabilities to address women Veterans' anxiety and depression treatment needs, thereby improving organizational primary care-mental health integration (PC-MHI) effectiveness and women Veterans' engagement and retention in PC-MHI. This implementation research study used mixed methods implementation evaluation to investigate primary implementation outcomes of adoption, acceptability, feasibility, and reach. Multilevel stakeholder engagement was prioritized. Program-wide organizational-, provider-, and patient-level data was utilized to enhance synergy, productivity, and impact. Several implementation outcomes were assessed using qualitative methods and will be reported elsewhere (e.g. final report, manuscripts).These include Adoption of Care Model, Acceptability of Care Model, Feasibility of Care Model, and Satisfaction With Care Model.

As a coherent program of women's health implementation research and quality improvement, the EMPOWER QUERI constituted a major milestone in achieving Blueprint for Excellence (BPE) strategies and realizing women Veterans' engagement and, ultimately, empowerment in the VHA system.

Study Type

Interventional

Enrollment (Actual)

153

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92161
        • VA San Diego Healthcare System, San Diego, CA
      • West Los Angeles, California, United States, 90073
        • VA Greater Los Angeles Healthcare System, West Los Angeles, CA
    • Oregon
      • Portland, Oregon, United States, 97239
        • VA Portland Health Care System, Portland, OR

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria

Patient Participants:

  • Women VA patients with possible or confirmed anxiety and/or depression and/or PTSD

Provider Participants:

  • VA staff in a primary care and/or mental health clinic

    • Note: gender based inclusion criteria did not apply to provider participants

Exclusion Criteria

Patient Participants:

  • Male gender
  • Cognitive impairment that would preclude completion of informed consent

Provider Participants:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Arm 1: Mixed Methods Implementation Evaluation
The investigators used mixed methods to evaluate the implementation in two VA Women's Practice Based Research Network (PBRN) sites, describing services and patterns of care utilized by patients prior to seeing a care manager, and then 30, 60, 180, and 365 days post initiation of care with the care manager. Investigators also evaluated facilitators and barriers to implementation of this collaborative care model.
This is a collaborative care model that focuses on identifying need for depression and/or anxiety care. Patients with possible anxiety and/or depression are referred to a care manager in primary care-mental health integration. The care manager then conducts a thorough assessment, offers the patient a variety of appropriate treatment options, and works with the patient to determine a care plan. One of the key options the investigators offered in this study is the Calm Tools for Living (CALM) intervention, which is focused on anxiety and which is rooted in patient preferences. Patients can choose web-based cognitive behavioral therapy (CBT) and/or pharmacologic treatment. In this study the investigators trained appropriate MH providers in CALM and studied the ways in which the intervention needs to be tailored to women Veterans.
Other Names:
  • Gender-Tailored Primary Care-Mental Health Integration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Referrals
Time Frame: baseline, 18 months (implementation phase)
Using the nonrandomized stepped wedge design, we will compare referrals to PC-MHI at baseline at each site, and compare to referrals throughout the 18-month implementation phase.
baseline, 18 months (implementation phase)
Altarum Consumer Engagement
Time Frame: 6 months
brief measure of patient engagement in care
6 months
Change in Utilization of Services (30 Days)
Time Frame: 30 days
Change in utilization of services comparing utilization 30 days prior to 30 days post initiation of care with the care manager.
30 days
Change in Utilization of Services (60 Days)
Time Frame: 60 days
Change in utilization of services comparing utilization 60 days prior to 60 days post initiation of care with the care manager.
60 days
Change in Utilization of Services (180 Days)
Time Frame: 180 days
Change in utilization of services 180 days prior to 180 days post initiation of care with the care manager.
180 days
Change in Utilization of Services (365 Days)
Time Frame: 365 days
Change in utilization of services comparing utilization 365 days prior to 365 days post initiation of care with the care manager.
365 days
Patient-Reported Outcomes Measurement Information System (PROMIS)
Time Frame: 6 months
brief measure of global health: Patient-Reported Outcomes Measurement Information System (PROMIS)
6 months
Overall Anxiety Severity and Impairment Scale (OASIS)
Time Frame: 6 months
brief measure of anxiety: Overall Anxiety Severity and Impairment Scale (OASIS)
6 months
Patient Health Questionnaire for Depression and Anxiety (PHQ-4)
Time Frame: 6 months
brief measure of depression: Patient Health Questionnaire for Depression and Anxiety (PHQ-4)
6 months
WHO Disability Assessment Schedule (WHODAS) Out Of Role Days Items
Time Frame: 6 months
brief measure of impact of disability on role functioning: WHO Disability Assessment Schedule (WHODAS) Out Of Role Days items
6 months
Global Rating of Satisfaction/Quality of Care
Time Frame: 6 months
brief measure of satisfaction and quality that we have used in several surveys of women Veteran VA patients
6 months
Health Literacy (Chew et al. 2004)
Time Frame: 6 months
brief measure of health literacy: (Chew et al. 2004)
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-Reported Outcomes Measurement Information System (PROMIS)
Time Frame: 6 months
brief measure of global health
6 months
Overall Anxiety Severity and Impairment Scale (OASIS)
Time Frame: 6 months
brief measure of anxiety
6 months
Patient Health Questionnaire for Depression and Anxiety (PHQ-4)
Time Frame: 6 months
brief measure of depression
6 months
WHO Disability Assessment Schedule (WHODAS) Out Of Role Days items
Time Frame: 6 months
brief measure of impact of disability on role functioning
6 months
Global rating of satisfaction/quality of care
Time Frame: 6 months
brief measure of satisfaction and quality that we have used in several surveys of women Veteran VA patients
6 months
Altarum Consumer Engagement
Time Frame: 6 months
brief measure of patient engagement in care
6 months
Health literacy (Chew et al. 2004)
Time Frame: 6 months
brief measure of health literacy
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alison B Hamilton, PhD MPH, VA Greater Los Angeles Healthcare System, West Los Angeles, CA
  • Principal Investigator: Ariel J. Lang, PhD, VA San Diego Healthcare System, San Diego, CA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 30, 2017

Primary Completion (Actual)

March 8, 2021

Study Completion (Actual)

March 8, 2021

Study Registration Dates

First Submitted

October 21, 2016

First Submitted That Met QC Criteria

October 27, 2016

First Posted (Estimated)

November 1, 2016

Study Record Updates

Last Update Posted (Actual)

March 18, 2024

Last Update Submitted That Met QC Criteria

August 30, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Collaborative Care for Women Veterans

3
Subscribe